Global Cancer Genome Sequencing Market Research Report 2024(Status and Outlook)
Report Overview
Cancer genome sequencing refers to a method used to identify the complete DNA or RNA sequence of cancer cells based on the sequencing of a single, homogeneous or heterogeneous group of tumor cells.
This report provides a deep insight into the global Cancer Genome Sequencing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cancer Genome Sequencing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cancer Genome Sequencing market in any manner.
Global Cancer Genome Sequencing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Agilent Technologies
GE Healthcare Life Sciences
Johnson & Johnson
LI-COR Biosciences
Abbott Laboratories
Beckman Coulter
Bayer
Hamilton Thorne Biosciences
Integrated DNA Technologies
Microchip Biotechnologies
Myriad Genetics
Commonwealth Biotechnologies
ZS Genetics
Pacific Biosciences
Market Segmentation (by Type)
Second Generation
Third Generation
Market Segmentation (by Application)
Treatment
Research
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cancer Genome Sequencing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Cancer genome sequencing refers to a method used to identify the complete DNA or RNA sequence of cancer cells based on the sequencing of a single, homogeneous or heterogeneous group of tumor cells.
This report provides a deep insight into the global Cancer Genome Sequencing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cancer Genome Sequencing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cancer Genome Sequencing market in any manner.
Global Cancer Genome Sequencing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Agilent Technologies
GE Healthcare Life Sciences
Johnson & Johnson
LI-COR Biosciences
Abbott Laboratories
Beckman Coulter
Bayer
Hamilton Thorne Biosciences
Integrated DNA Technologies
Microchip Biotechnologies
Myriad Genetics
Commonwealth Biotechnologies
ZS Genetics
Pacific Biosciences
Market Segmentation (by Type)
Second Generation
Third Generation
Market Segmentation (by Application)
Treatment
Research
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Cancer Genome Sequencing Market
- Overview of the regional outlook of the Cancer Genome Sequencing Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cancer Genome Sequencing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Cancer Genome Sequencing
1.2 Key Market Segments
1.2.1 Cancer Genome Sequencing Segment by Type
1.2.2 Cancer Genome Sequencing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CANCER GENOME SEQUENCING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cancer Genome Sequencing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Cancer Genome Sequencing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CANCER GENOME SEQUENCING MARKET COMPETITIVE LANDSCAPE
3.1 Global Cancer Genome Sequencing Sales by Manufacturers (2019-2024)
3.2 Global Cancer Genome Sequencing Revenue Market Share by Manufacturers (2019-2024)
3.3 Cancer Genome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cancer Genome Sequencing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cancer Genome Sequencing Sales Sites, Area Served, Product Type
3.6 Cancer Genome Sequencing Market Competitive Situation and Trends
3.6.1 Cancer Genome Sequencing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cancer Genome Sequencing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CANCER GENOME SEQUENCING INDUSTRY CHAIN ANALYSIS
4.1 Cancer Genome Sequencing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CANCER GENOME SEQUENCING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CANCER GENOME SEQUENCING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cancer Genome Sequencing Sales Market Share by Type (2019-2024)
6.3 Global Cancer Genome Sequencing Market Size Market Share by Type (2019-2024)
6.4 Global Cancer Genome Sequencing Price by Type (2019-2024)
7 CANCER GENOME SEQUENCING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cancer Genome Sequencing Market Sales by Application (2019-2024)
7.3 Global Cancer Genome Sequencing Market Size (M USD) by Application (2019-2024)
7.4 Global Cancer Genome Sequencing Sales Growth Rate by Application (2019-2024)
8 CANCER GENOME SEQUENCING MARKET SEGMENTATION BY REGION
8.1 Global Cancer Genome Sequencing Sales by Region
8.1.1 Global Cancer Genome Sequencing Sales by Region
8.1.2 Global Cancer Genome Sequencing Sales Market Share by Region
8.2 North America
8.2.1 North America Cancer Genome Sequencing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cancer Genome Sequencing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cancer Genome Sequencing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cancer Genome Sequencing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cancer Genome Sequencing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Agilent Technologies
9.1.1 Agilent Technologies Cancer Genome Sequencing Basic Information
9.1.2 Agilent Technologies Cancer Genome Sequencing Product Overview
9.1.3 Agilent Technologies Cancer Genome Sequencing Product Market Performance
9.1.4 Agilent Technologies Business Overview
9.1.5 Agilent Technologies Cancer Genome Sequencing SWOT Analysis
9.1.6 Agilent Technologies Recent Developments
9.2 GE Healthcare Life Sciences
9.2.1 GE Healthcare Life Sciences Cancer Genome Sequencing Basic Information
9.2.2 GE Healthcare Life Sciences Cancer Genome Sequencing Product Overview
9.2.3 GE Healthcare Life Sciences Cancer Genome Sequencing Product Market Performance
9.2.4 GE Healthcare Life Sciences Business Overview
9.2.5 GE Healthcare Life Sciences Cancer Genome Sequencing SWOT Analysis
9.2.6 GE Healthcare Life Sciences Recent Developments
9.3 Johnson and Johnson
9.3.1 Johnson and Johnson Cancer Genome Sequencing Basic Information
9.3.2 Johnson and Johnson Cancer Genome Sequencing Product Overview
9.3.3 Johnson and Johnson Cancer Genome Sequencing Product Market Performance
9.3.4 Johnson and Johnson Cancer Genome Sequencing SWOT Analysis
9.3.5 Johnson and Johnson Business Overview
9.3.6 Johnson and Johnson Recent Developments
9.4 LI-COR Biosciences
9.4.1 LI-COR Biosciences Cancer Genome Sequencing Basic Information
9.4.2 LI-COR Biosciences Cancer Genome Sequencing Product Overview
9.4.3 LI-COR Biosciences Cancer Genome Sequencing Product Market Performance
9.4.4 LI-COR Biosciences Business Overview
9.4.5 LI-COR Biosciences Recent Developments
9.5 Abbott Laboratories
9.5.1 Abbott Laboratories Cancer Genome Sequencing Basic Information
9.5.2 Abbott Laboratories Cancer Genome Sequencing Product Overview
9.5.3 Abbott Laboratories Cancer Genome Sequencing Product Market Performance
9.5.4 Abbott Laboratories Business Overview
9.5.5 Abbott Laboratories Recent Developments
9.6 Beckman Coulter
9.6.1 Beckman Coulter Cancer Genome Sequencing Basic Information
9.6.2 Beckman Coulter Cancer Genome Sequencing Product Overview
9.6.3 Beckman Coulter Cancer Genome Sequencing Product Market Performance
9.6.4 Beckman Coulter Business Overview
9.6.5 Beckman Coulter Recent Developments
9.7 Bayer
9.7.1 Bayer Cancer Genome Sequencing Basic Information
9.7.2 Bayer Cancer Genome Sequencing Product Overview
9.7.3 Bayer Cancer Genome Sequencing Product Market Performance
9.7.4 Bayer Business Overview
9.7.5 Bayer Recent Developments
9.8 Hamilton Thorne Biosciences
9.8.1 Hamilton Thorne Biosciences Cancer Genome Sequencing Basic Information
9.8.2 Hamilton Thorne Biosciences Cancer Genome Sequencing Product Overview
9.8.3 Hamilton Thorne Biosciences Cancer Genome Sequencing Product Market Performance
9.8.4 Hamilton Thorne Biosciences Business Overview
9.8.5 Hamilton Thorne Biosciences Recent Developments
9.9 Integrated DNA Technologies
9.9.1 Integrated DNA Technologies Cancer Genome Sequencing Basic Information
9.9.2 Integrated DNA Technologies Cancer Genome Sequencing Product Overview
9.9.3 Integrated DNA Technologies Cancer Genome Sequencing Product Market Performance
9.9.4 Integrated DNA Technologies Business Overview
9.9.5 Integrated DNA Technologies Recent Developments
9.10 Microchip Biotechnologies
9.10.1 Microchip Biotechnologies Cancer Genome Sequencing Basic Information
9.10.2 Microchip Biotechnologies Cancer Genome Sequencing Product Overview
9.10.3 Microchip Biotechnologies Cancer Genome Sequencing Product Market Performance
9.10.4 Microchip Biotechnologies Business Overview
9.10.5 Microchip Biotechnologies Recent Developments
9.11 Myriad Genetics
9.11.1 Myriad Genetics Cancer Genome Sequencing Basic Information
9.11.2 Myriad Genetics Cancer Genome Sequencing Product Overview
9.11.3 Myriad Genetics Cancer Genome Sequencing Product Market Performance
9.11.4 Myriad Genetics Business Overview
9.11.5 Myriad Genetics Recent Developments
9.12 Commonwealth Biotechnologies
9.12.1 Commonwealth Biotechnologies Cancer Genome Sequencing Basic Information
9.12.2 Commonwealth Biotechnologies Cancer Genome Sequencing Product Overview
9.12.3 Commonwealth Biotechnologies Cancer Genome Sequencing Product Market Performance
9.12.4 Commonwealth Biotechnologies Business Overview
9.12.5 Commonwealth Biotechnologies Recent Developments
9.13 ZS Genetics
9.13.1 ZS Genetics Cancer Genome Sequencing Basic Information
9.13.2 ZS Genetics Cancer Genome Sequencing Product Overview
9.13.3 ZS Genetics Cancer Genome Sequencing Product Market Performance
9.13.4 ZS Genetics Business Overview
9.13.5 ZS Genetics Recent Developments
9.14 Pacific Biosciences
9.14.1 Pacific Biosciences Cancer Genome Sequencing Basic Information
9.14.2 Pacific Biosciences Cancer Genome Sequencing Product Overview
9.14.3 Pacific Biosciences Cancer Genome Sequencing Product Market Performance
9.14.4 Pacific Biosciences Business Overview
9.14.5 Pacific Biosciences Recent Developments
10 CANCER GENOME SEQUENCING MARKET FORECAST BY REGION
10.1 Global Cancer Genome Sequencing Market Size Forecast
10.2 Global Cancer Genome Sequencing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cancer Genome Sequencing Market Size Forecast by Country
10.2.3 Asia Pacific Cancer Genome Sequencing Market Size Forecast by Region
10.2.4 South America Cancer Genome Sequencing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cancer Genome Sequencing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Cancer Genome Sequencing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Cancer Genome Sequencing by Type (2025-2030)
11.1.2 Global Cancer Genome Sequencing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Cancer Genome Sequencing by Type (2025-2030)
11.2 Global Cancer Genome Sequencing Market Forecast by Application (2025-2030)
11.2.1 Global Cancer Genome Sequencing Sales (K Units) Forecast by Application
11.2.2 Global Cancer Genome Sequencing Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Cancer Genome Sequencing
1.2 Key Market Segments
1.2.1 Cancer Genome Sequencing Segment by Type
1.2.2 Cancer Genome Sequencing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CANCER GENOME SEQUENCING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cancer Genome Sequencing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Cancer Genome Sequencing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CANCER GENOME SEQUENCING MARKET COMPETITIVE LANDSCAPE
3.1 Global Cancer Genome Sequencing Sales by Manufacturers (2019-2024)
3.2 Global Cancer Genome Sequencing Revenue Market Share by Manufacturers (2019-2024)
3.3 Cancer Genome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cancer Genome Sequencing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cancer Genome Sequencing Sales Sites, Area Served, Product Type
3.6 Cancer Genome Sequencing Market Competitive Situation and Trends
3.6.1 Cancer Genome Sequencing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cancer Genome Sequencing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CANCER GENOME SEQUENCING INDUSTRY CHAIN ANALYSIS
4.1 Cancer Genome Sequencing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CANCER GENOME SEQUENCING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CANCER GENOME SEQUENCING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cancer Genome Sequencing Sales Market Share by Type (2019-2024)
6.3 Global Cancer Genome Sequencing Market Size Market Share by Type (2019-2024)
6.4 Global Cancer Genome Sequencing Price by Type (2019-2024)
7 CANCER GENOME SEQUENCING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cancer Genome Sequencing Market Sales by Application (2019-2024)
7.3 Global Cancer Genome Sequencing Market Size (M USD) by Application (2019-2024)
7.4 Global Cancer Genome Sequencing Sales Growth Rate by Application (2019-2024)
8 CANCER GENOME SEQUENCING MARKET SEGMENTATION BY REGION
8.1 Global Cancer Genome Sequencing Sales by Region
8.1.1 Global Cancer Genome Sequencing Sales by Region
8.1.2 Global Cancer Genome Sequencing Sales Market Share by Region
8.2 North America
8.2.1 North America Cancer Genome Sequencing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cancer Genome Sequencing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cancer Genome Sequencing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cancer Genome Sequencing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cancer Genome Sequencing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Agilent Technologies
9.1.1 Agilent Technologies Cancer Genome Sequencing Basic Information
9.1.2 Agilent Technologies Cancer Genome Sequencing Product Overview
9.1.3 Agilent Technologies Cancer Genome Sequencing Product Market Performance
9.1.4 Agilent Technologies Business Overview
9.1.5 Agilent Technologies Cancer Genome Sequencing SWOT Analysis
9.1.6 Agilent Technologies Recent Developments
9.2 GE Healthcare Life Sciences
9.2.1 GE Healthcare Life Sciences Cancer Genome Sequencing Basic Information
9.2.2 GE Healthcare Life Sciences Cancer Genome Sequencing Product Overview
9.2.3 GE Healthcare Life Sciences Cancer Genome Sequencing Product Market Performance
9.2.4 GE Healthcare Life Sciences Business Overview
9.2.5 GE Healthcare Life Sciences Cancer Genome Sequencing SWOT Analysis
9.2.6 GE Healthcare Life Sciences Recent Developments
9.3 Johnson and Johnson
9.3.1 Johnson and Johnson Cancer Genome Sequencing Basic Information
9.3.2 Johnson and Johnson Cancer Genome Sequencing Product Overview
9.3.3 Johnson and Johnson Cancer Genome Sequencing Product Market Performance
9.3.4 Johnson and Johnson Cancer Genome Sequencing SWOT Analysis
9.3.5 Johnson and Johnson Business Overview
9.3.6 Johnson and Johnson Recent Developments
9.4 LI-COR Biosciences
9.4.1 LI-COR Biosciences Cancer Genome Sequencing Basic Information
9.4.2 LI-COR Biosciences Cancer Genome Sequencing Product Overview
9.4.3 LI-COR Biosciences Cancer Genome Sequencing Product Market Performance
9.4.4 LI-COR Biosciences Business Overview
9.4.5 LI-COR Biosciences Recent Developments
9.5 Abbott Laboratories
9.5.1 Abbott Laboratories Cancer Genome Sequencing Basic Information
9.5.2 Abbott Laboratories Cancer Genome Sequencing Product Overview
9.5.3 Abbott Laboratories Cancer Genome Sequencing Product Market Performance
9.5.4 Abbott Laboratories Business Overview
9.5.5 Abbott Laboratories Recent Developments
9.6 Beckman Coulter
9.6.1 Beckman Coulter Cancer Genome Sequencing Basic Information
9.6.2 Beckman Coulter Cancer Genome Sequencing Product Overview
9.6.3 Beckman Coulter Cancer Genome Sequencing Product Market Performance
9.6.4 Beckman Coulter Business Overview
9.6.5 Beckman Coulter Recent Developments
9.7 Bayer
9.7.1 Bayer Cancer Genome Sequencing Basic Information
9.7.2 Bayer Cancer Genome Sequencing Product Overview
9.7.3 Bayer Cancer Genome Sequencing Product Market Performance
9.7.4 Bayer Business Overview
9.7.5 Bayer Recent Developments
9.8 Hamilton Thorne Biosciences
9.8.1 Hamilton Thorne Biosciences Cancer Genome Sequencing Basic Information
9.8.2 Hamilton Thorne Biosciences Cancer Genome Sequencing Product Overview
9.8.3 Hamilton Thorne Biosciences Cancer Genome Sequencing Product Market Performance
9.8.4 Hamilton Thorne Biosciences Business Overview
9.8.5 Hamilton Thorne Biosciences Recent Developments
9.9 Integrated DNA Technologies
9.9.1 Integrated DNA Technologies Cancer Genome Sequencing Basic Information
9.9.2 Integrated DNA Technologies Cancer Genome Sequencing Product Overview
9.9.3 Integrated DNA Technologies Cancer Genome Sequencing Product Market Performance
9.9.4 Integrated DNA Technologies Business Overview
9.9.5 Integrated DNA Technologies Recent Developments
9.10 Microchip Biotechnologies
9.10.1 Microchip Biotechnologies Cancer Genome Sequencing Basic Information
9.10.2 Microchip Biotechnologies Cancer Genome Sequencing Product Overview
9.10.3 Microchip Biotechnologies Cancer Genome Sequencing Product Market Performance
9.10.4 Microchip Biotechnologies Business Overview
9.10.5 Microchip Biotechnologies Recent Developments
9.11 Myriad Genetics
9.11.1 Myriad Genetics Cancer Genome Sequencing Basic Information
9.11.2 Myriad Genetics Cancer Genome Sequencing Product Overview
9.11.3 Myriad Genetics Cancer Genome Sequencing Product Market Performance
9.11.4 Myriad Genetics Business Overview
9.11.5 Myriad Genetics Recent Developments
9.12 Commonwealth Biotechnologies
9.12.1 Commonwealth Biotechnologies Cancer Genome Sequencing Basic Information
9.12.2 Commonwealth Biotechnologies Cancer Genome Sequencing Product Overview
9.12.3 Commonwealth Biotechnologies Cancer Genome Sequencing Product Market Performance
9.12.4 Commonwealth Biotechnologies Business Overview
9.12.5 Commonwealth Biotechnologies Recent Developments
9.13 ZS Genetics
9.13.1 ZS Genetics Cancer Genome Sequencing Basic Information
9.13.2 ZS Genetics Cancer Genome Sequencing Product Overview
9.13.3 ZS Genetics Cancer Genome Sequencing Product Market Performance
9.13.4 ZS Genetics Business Overview
9.13.5 ZS Genetics Recent Developments
9.14 Pacific Biosciences
9.14.1 Pacific Biosciences Cancer Genome Sequencing Basic Information
9.14.2 Pacific Biosciences Cancer Genome Sequencing Product Overview
9.14.3 Pacific Biosciences Cancer Genome Sequencing Product Market Performance
9.14.4 Pacific Biosciences Business Overview
9.14.5 Pacific Biosciences Recent Developments
10 CANCER GENOME SEQUENCING MARKET FORECAST BY REGION
10.1 Global Cancer Genome Sequencing Market Size Forecast
10.2 Global Cancer Genome Sequencing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cancer Genome Sequencing Market Size Forecast by Country
10.2.3 Asia Pacific Cancer Genome Sequencing Market Size Forecast by Region
10.2.4 South America Cancer Genome Sequencing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cancer Genome Sequencing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Cancer Genome Sequencing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Cancer Genome Sequencing by Type (2025-2030)
11.1.2 Global Cancer Genome Sequencing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Cancer Genome Sequencing by Type (2025-2030)
11.2 Global Cancer Genome Sequencing Market Forecast by Application (2025-2030)
11.2.1 Global Cancer Genome Sequencing Sales (K Units) Forecast by Application
11.2.2 Global Cancer Genome Sequencing Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cancer Genome Sequencing Market Size Comparison by Region (M USD)
Table 5. Global Cancer Genome Sequencing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Cancer Genome Sequencing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Cancer Genome Sequencing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Cancer Genome Sequencing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Genome Sequencing as of 2022)
Table 10. Global Market Cancer Genome Sequencing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Cancer Genome Sequencing Sales Sites and Area Served
Table 12. Manufacturers Cancer Genome Sequencing Product Type
Table 13. Global Cancer Genome Sequencing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Cancer Genome Sequencing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cancer Genome Sequencing Market Challenges
Table 22. Global Cancer Genome Sequencing Sales by Type (K Units)
Table 23. Global Cancer Genome Sequencing Market Size by Type (M USD)
Table 24. Global Cancer Genome Sequencing Sales (K Units) by Type (2019-2024)
Table 25. Global Cancer Genome Sequencing Sales Market Share by Type (2019-2024)
Table 26. Global Cancer Genome Sequencing Market Size (M USD) by Type (2019-2024)
Table 27. Global Cancer Genome Sequencing Market Size Share by Type (2019-2024)
Table 28. Global Cancer Genome Sequencing Price (USD/Unit) by Type (2019-2024)
Table 29. Global Cancer Genome Sequencing Sales (K Units) by Application
Table 30. Global Cancer Genome Sequencing Market Size by Application
Table 31. Global Cancer Genome Sequencing Sales by Application (2019-2024) & (K Units)
Table 32. Global Cancer Genome Sequencing Sales Market Share by Application (2019-2024)
Table 33. Global Cancer Genome Sequencing Sales by Application (2019-2024) & (M USD)
Table 34. Global Cancer Genome Sequencing Market Share by Application (2019-2024)
Table 35. Global Cancer Genome Sequencing Sales Growth Rate by Application (2019-2024)
Table 36. Global Cancer Genome Sequencing Sales by Region (2019-2024) & (K Units)
Table 37. Global Cancer Genome Sequencing Sales Market Share by Region (2019-2024)
Table 38. North America Cancer Genome Sequencing Sales by Country (2019-2024) & (K Units)
Table 39. Europe Cancer Genome Sequencing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Cancer Genome Sequencing Sales by Region (2019-2024) & (K Units)
Table 41. South America Cancer Genome Sequencing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Cancer Genome Sequencing Sales by Region (2019-2024) & (K Units)
Table 43. Agilent Technologies Cancer Genome Sequencing Basic Information
Table 44. Agilent Technologies Cancer Genome Sequencing Product Overview
Table 45. Agilent Technologies Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Agilent Technologies Business Overview
Table 47. Agilent Technologies Cancer Genome Sequencing SWOT Analysis
Table 48. Agilent Technologies Recent Developments
Table 49. GE Healthcare Life Sciences Cancer Genome Sequencing Basic Information
Table 50. GE Healthcare Life Sciences Cancer Genome Sequencing Product Overview
Table 51. GE Healthcare Life Sciences Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. GE Healthcare Life Sciences Business Overview
Table 53. GE Healthcare Life Sciences Cancer Genome Sequencing SWOT Analysis
Table 54. GE Healthcare Life Sciences Recent Developments
Table 55. Johnson and Johnson Cancer Genome Sequencing Basic Information
Table 56. Johnson and Johnson Cancer Genome Sequencing Product Overview
Table 57. Johnson and Johnson Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Johnson and Johnson Cancer Genome Sequencing SWOT Analysis
Table 59. Johnson and Johnson Business Overview
Table 60. Johnson and Johnson Recent Developments
Table 61. LI-COR Biosciences Cancer Genome Sequencing Basic Information
Table 62. LI-COR Biosciences Cancer Genome Sequencing Product Overview
Table 63. LI-COR Biosciences Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. LI-COR Biosciences Business Overview
Table 65. LI-COR Biosciences Recent Developments
Table 66. Abbott Laboratories Cancer Genome Sequencing Basic Information
Table 67. Abbott Laboratories Cancer Genome Sequencing Product Overview
Table 68. Abbott Laboratories Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Abbott Laboratories Business Overview
Table 70. Abbott Laboratories Recent Developments
Table 71. Beckman Coulter Cancer Genome Sequencing Basic Information
Table 72. Beckman Coulter Cancer Genome Sequencing Product Overview
Table 73. Beckman Coulter Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Beckman Coulter Business Overview
Table 75. Beckman Coulter Recent Developments
Table 76. Bayer Cancer Genome Sequencing Basic Information
Table 77. Bayer Cancer Genome Sequencing Product Overview
Table 78. Bayer Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Bayer Business Overview
Table 80. Bayer Recent Developments
Table 81. Hamilton Thorne Biosciences Cancer Genome Sequencing Basic Information
Table 82. Hamilton Thorne Biosciences Cancer Genome Sequencing Product Overview
Table 83. Hamilton Thorne Biosciences Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Hamilton Thorne Biosciences Business Overview
Table 85. Hamilton Thorne Biosciences Recent Developments
Table 86. Integrated DNA Technologies Cancer Genome Sequencing Basic Information
Table 87. Integrated DNA Technologies Cancer Genome Sequencing Product Overview
Table 88. Integrated DNA Technologies Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Integrated DNA Technologies Business Overview
Table 90. Integrated DNA Technologies Recent Developments
Table 91. Microchip Biotechnologies Cancer Genome Sequencing Basic Information
Table 92. Microchip Biotechnologies Cancer Genome Sequencing Product Overview
Table 93. Microchip Biotechnologies Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Microchip Biotechnologies Business Overview
Table 95. Microchip Biotechnologies Recent Developments
Table 96. Myriad Genetics Cancer Genome Sequencing Basic Information
Table 97. Myriad Genetics Cancer Genome Sequencing Product Overview
Table 98. Myriad Genetics Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Myriad Genetics Business Overview
Table 100. Myriad Genetics Recent Developments
Table 101. Commonwealth Biotechnologies Cancer Genome Sequencing Basic Information
Table 102. Commonwealth Biotechnologies Cancer Genome Sequencing Product Overview
Table 103. Commonwealth Biotechnologies Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Commonwealth Biotechnologies Business Overview
Table 105. Commonwealth Biotechnologies Recent Developments
Table 106. ZS Genetics Cancer Genome Sequencing Basic Information
Table 107. ZS Genetics Cancer Genome Sequencing Product Overview
Table 108. ZS Genetics Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. ZS Genetics Business Overview
Table 110. ZS Genetics Recent Developments
Table 111. Pacific Biosciences Cancer Genome Sequencing Basic Information
Table 112. Pacific Biosciences Cancer Genome Sequencing Product Overview
Table 113. Pacific Biosciences Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Pacific Biosciences Business Overview
Table 115. Pacific Biosciences Recent Developments
Table 116. Global Cancer Genome Sequencing Sales Forecast by Region (2025-2030) & (K Units)
Table 117. Global Cancer Genome Sequencing Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America Cancer Genome Sequencing Sales Forecast by Country (2025-2030) & (K Units)
Table 119. North America Cancer Genome Sequencing Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe Cancer Genome Sequencing Sales Forecast by Country (2025-2030) & (K Units)
Table 121. Europe Cancer Genome Sequencing Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific Cancer Genome Sequencing Sales Forecast by Region (2025-2030) & (K Units)
Table 123. Asia Pacific Cancer Genome Sequencing Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America Cancer Genome Sequencing Sales Forecast by Country (2025-2030) & (K Units)
Table 125. South America Cancer Genome Sequencing Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa Cancer Genome Sequencing Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa Cancer Genome Sequencing Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global Cancer Genome Sequencing Sales Forecast by Type (2025-2030) & (K Units)
Table 129. Global Cancer Genome Sequencing Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global Cancer Genome Sequencing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 131. Global Cancer Genome Sequencing Sales (K Units) Forecast by Application (2025-2030)
Table 132. Global Cancer Genome Sequencing Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cancer Genome Sequencing Market Size Comparison by Region (M USD)
Table 5. Global Cancer Genome Sequencing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Cancer Genome Sequencing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Cancer Genome Sequencing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Cancer Genome Sequencing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Genome Sequencing as of 2022)
Table 10. Global Market Cancer Genome Sequencing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Cancer Genome Sequencing Sales Sites and Area Served
Table 12. Manufacturers Cancer Genome Sequencing Product Type
Table 13. Global Cancer Genome Sequencing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Cancer Genome Sequencing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cancer Genome Sequencing Market Challenges
Table 22. Global Cancer Genome Sequencing Sales by Type (K Units)
Table 23. Global Cancer Genome Sequencing Market Size by Type (M USD)
Table 24. Global Cancer Genome Sequencing Sales (K Units) by Type (2019-2024)
Table 25. Global Cancer Genome Sequencing Sales Market Share by Type (2019-2024)
Table 26. Global Cancer Genome Sequencing Market Size (M USD) by Type (2019-2024)
Table 27. Global Cancer Genome Sequencing Market Size Share by Type (2019-2024)
Table 28. Global Cancer Genome Sequencing Price (USD/Unit) by Type (2019-2024)
Table 29. Global Cancer Genome Sequencing Sales (K Units) by Application
Table 30. Global Cancer Genome Sequencing Market Size by Application
Table 31. Global Cancer Genome Sequencing Sales by Application (2019-2024) & (K Units)
Table 32. Global Cancer Genome Sequencing Sales Market Share by Application (2019-2024)
Table 33. Global Cancer Genome Sequencing Sales by Application (2019-2024) & (M USD)
Table 34. Global Cancer Genome Sequencing Market Share by Application (2019-2024)
Table 35. Global Cancer Genome Sequencing Sales Growth Rate by Application (2019-2024)
Table 36. Global Cancer Genome Sequencing Sales by Region (2019-2024) & (K Units)
Table 37. Global Cancer Genome Sequencing Sales Market Share by Region (2019-2024)
Table 38. North America Cancer Genome Sequencing Sales by Country (2019-2024) & (K Units)
Table 39. Europe Cancer Genome Sequencing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Cancer Genome Sequencing Sales by Region (2019-2024) & (K Units)
Table 41. South America Cancer Genome Sequencing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Cancer Genome Sequencing Sales by Region (2019-2024) & (K Units)
Table 43. Agilent Technologies Cancer Genome Sequencing Basic Information
Table 44. Agilent Technologies Cancer Genome Sequencing Product Overview
Table 45. Agilent Technologies Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Agilent Technologies Business Overview
Table 47. Agilent Technologies Cancer Genome Sequencing SWOT Analysis
Table 48. Agilent Technologies Recent Developments
Table 49. GE Healthcare Life Sciences Cancer Genome Sequencing Basic Information
Table 50. GE Healthcare Life Sciences Cancer Genome Sequencing Product Overview
Table 51. GE Healthcare Life Sciences Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. GE Healthcare Life Sciences Business Overview
Table 53. GE Healthcare Life Sciences Cancer Genome Sequencing SWOT Analysis
Table 54. GE Healthcare Life Sciences Recent Developments
Table 55. Johnson and Johnson Cancer Genome Sequencing Basic Information
Table 56. Johnson and Johnson Cancer Genome Sequencing Product Overview
Table 57. Johnson and Johnson Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Johnson and Johnson Cancer Genome Sequencing SWOT Analysis
Table 59. Johnson and Johnson Business Overview
Table 60. Johnson and Johnson Recent Developments
Table 61. LI-COR Biosciences Cancer Genome Sequencing Basic Information
Table 62. LI-COR Biosciences Cancer Genome Sequencing Product Overview
Table 63. LI-COR Biosciences Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. LI-COR Biosciences Business Overview
Table 65. LI-COR Biosciences Recent Developments
Table 66. Abbott Laboratories Cancer Genome Sequencing Basic Information
Table 67. Abbott Laboratories Cancer Genome Sequencing Product Overview
Table 68. Abbott Laboratories Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Abbott Laboratories Business Overview
Table 70. Abbott Laboratories Recent Developments
Table 71. Beckman Coulter Cancer Genome Sequencing Basic Information
Table 72. Beckman Coulter Cancer Genome Sequencing Product Overview
Table 73. Beckman Coulter Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Beckman Coulter Business Overview
Table 75. Beckman Coulter Recent Developments
Table 76. Bayer Cancer Genome Sequencing Basic Information
Table 77. Bayer Cancer Genome Sequencing Product Overview
Table 78. Bayer Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Bayer Business Overview
Table 80. Bayer Recent Developments
Table 81. Hamilton Thorne Biosciences Cancer Genome Sequencing Basic Information
Table 82. Hamilton Thorne Biosciences Cancer Genome Sequencing Product Overview
Table 83. Hamilton Thorne Biosciences Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Hamilton Thorne Biosciences Business Overview
Table 85. Hamilton Thorne Biosciences Recent Developments
Table 86. Integrated DNA Technologies Cancer Genome Sequencing Basic Information
Table 87. Integrated DNA Technologies Cancer Genome Sequencing Product Overview
Table 88. Integrated DNA Technologies Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Integrated DNA Technologies Business Overview
Table 90. Integrated DNA Technologies Recent Developments
Table 91. Microchip Biotechnologies Cancer Genome Sequencing Basic Information
Table 92. Microchip Biotechnologies Cancer Genome Sequencing Product Overview
Table 93. Microchip Biotechnologies Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Microchip Biotechnologies Business Overview
Table 95. Microchip Biotechnologies Recent Developments
Table 96. Myriad Genetics Cancer Genome Sequencing Basic Information
Table 97. Myriad Genetics Cancer Genome Sequencing Product Overview
Table 98. Myriad Genetics Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Myriad Genetics Business Overview
Table 100. Myriad Genetics Recent Developments
Table 101. Commonwealth Biotechnologies Cancer Genome Sequencing Basic Information
Table 102. Commonwealth Biotechnologies Cancer Genome Sequencing Product Overview
Table 103. Commonwealth Biotechnologies Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Commonwealth Biotechnologies Business Overview
Table 105. Commonwealth Biotechnologies Recent Developments
Table 106. ZS Genetics Cancer Genome Sequencing Basic Information
Table 107. ZS Genetics Cancer Genome Sequencing Product Overview
Table 108. ZS Genetics Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. ZS Genetics Business Overview
Table 110. ZS Genetics Recent Developments
Table 111. Pacific Biosciences Cancer Genome Sequencing Basic Information
Table 112. Pacific Biosciences Cancer Genome Sequencing Product Overview
Table 113. Pacific Biosciences Cancer Genome Sequencing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Pacific Biosciences Business Overview
Table 115. Pacific Biosciences Recent Developments
Table 116. Global Cancer Genome Sequencing Sales Forecast by Region (2025-2030) & (K Units)
Table 117. Global Cancer Genome Sequencing Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America Cancer Genome Sequencing Sales Forecast by Country (2025-2030) & (K Units)
Table 119. North America Cancer Genome Sequencing Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe Cancer Genome Sequencing Sales Forecast by Country (2025-2030) & (K Units)
Table 121. Europe Cancer Genome Sequencing Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific Cancer Genome Sequencing Sales Forecast by Region (2025-2030) & (K Units)
Table 123. Asia Pacific Cancer Genome Sequencing Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America Cancer Genome Sequencing Sales Forecast by Country (2025-2030) & (K Units)
Table 125. South America Cancer Genome Sequencing Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa Cancer Genome Sequencing Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa Cancer Genome Sequencing Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global Cancer Genome Sequencing Sales Forecast by Type (2025-2030) & (K Units)
Table 129. Global Cancer Genome Sequencing Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global Cancer Genome Sequencing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 131. Global Cancer Genome Sequencing Sales (K Units) Forecast by Application (2025-2030)
Table 132. Global Cancer Genome Sequencing Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Cancer Genome Sequencing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cancer Genome Sequencing Market Size (M USD), 2019-2030
Figure 5. Global Cancer Genome Sequencing Market Size (M USD) (2019-2030)
Figure 6. Global Cancer Genome Sequencing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cancer Genome Sequencing Market Size by Country (M USD)
Figure 11. Cancer Genome Sequencing Sales Share by Manufacturers in 2023
Figure 12. Global Cancer Genome Sequencing Revenue Share by Manufacturers in 2023
Figure 13. Cancer Genome Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Cancer Genome Sequencing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Cancer Genome Sequencing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Cancer Genome Sequencing Market Share by Type
Figure 18. Sales Market Share of Cancer Genome Sequencing by Type (2019-2024)
Figure 19. Sales Market Share of Cancer Genome Sequencing by Type in 2023
Figure 20. Market Size Share of Cancer Genome Sequencing by Type (2019-2024)
Figure 21. Market Size Market Share of Cancer Genome Sequencing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cancer Genome Sequencing Market Share by Application
Figure 24. Global Cancer Genome Sequencing Sales Market Share by Application (2019-2024)
Figure 25. Global Cancer Genome Sequencing Sales Market Share by Application in 2023
Figure 26. Global Cancer Genome Sequencing Market Share by Application (2019-2024)
Figure 27. Global Cancer Genome Sequencing Market Share by Application in 2023
Figure 28. Global Cancer Genome Sequencing Sales Growth Rate by Application (2019-2024)
Figure 29. Global Cancer Genome Sequencing Sales Market Share by Region (2019-2024)
Figure 30. North America Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Cancer Genome Sequencing Sales Market Share by Country in 2023
Figure 32. U.S. Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Cancer Genome Sequencing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Cancer Genome Sequencing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Cancer Genome Sequencing Sales Market Share by Country in 2023
Figure 37. Germany Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Cancer Genome Sequencing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Cancer Genome Sequencing Sales Market Share by Region in 2023
Figure 44. China Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Cancer Genome Sequencing Sales and Growth Rate (K Units)
Figure 50. South America Cancer Genome Sequencing Sales Market Share by Country in 2023
Figure 51. Brazil Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Cancer Genome Sequencing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Cancer Genome Sequencing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Cancer Genome Sequencing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Cancer Genome Sequencing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Cancer Genome Sequencing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Cancer Genome Sequencing Market Share Forecast by Type (2025-2030)
Figure 65. Global Cancer Genome Sequencing Sales Forecast by Application (2025-2030)
Figure 66. Global Cancer Genome Sequencing Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Cancer Genome Sequencing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cancer Genome Sequencing Market Size (M USD), 2019-2030
Figure 5. Global Cancer Genome Sequencing Market Size (M USD) (2019-2030)
Figure 6. Global Cancer Genome Sequencing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cancer Genome Sequencing Market Size by Country (M USD)
Figure 11. Cancer Genome Sequencing Sales Share by Manufacturers in 2023
Figure 12. Global Cancer Genome Sequencing Revenue Share by Manufacturers in 2023
Figure 13. Cancer Genome Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Cancer Genome Sequencing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Cancer Genome Sequencing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Cancer Genome Sequencing Market Share by Type
Figure 18. Sales Market Share of Cancer Genome Sequencing by Type (2019-2024)
Figure 19. Sales Market Share of Cancer Genome Sequencing by Type in 2023
Figure 20. Market Size Share of Cancer Genome Sequencing by Type (2019-2024)
Figure 21. Market Size Market Share of Cancer Genome Sequencing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cancer Genome Sequencing Market Share by Application
Figure 24. Global Cancer Genome Sequencing Sales Market Share by Application (2019-2024)
Figure 25. Global Cancer Genome Sequencing Sales Market Share by Application in 2023
Figure 26. Global Cancer Genome Sequencing Market Share by Application (2019-2024)
Figure 27. Global Cancer Genome Sequencing Market Share by Application in 2023
Figure 28. Global Cancer Genome Sequencing Sales Growth Rate by Application (2019-2024)
Figure 29. Global Cancer Genome Sequencing Sales Market Share by Region (2019-2024)
Figure 30. North America Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Cancer Genome Sequencing Sales Market Share by Country in 2023
Figure 32. U.S. Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Cancer Genome Sequencing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Cancer Genome Sequencing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Cancer Genome Sequencing Sales Market Share by Country in 2023
Figure 37. Germany Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Cancer Genome Sequencing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Cancer Genome Sequencing Sales Market Share by Region in 2023
Figure 44. China Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Cancer Genome Sequencing Sales and Growth Rate (K Units)
Figure 50. South America Cancer Genome Sequencing Sales Market Share by Country in 2023
Figure 51. Brazil Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Cancer Genome Sequencing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Cancer Genome Sequencing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Cancer Genome Sequencing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Cancer Genome Sequencing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Cancer Genome Sequencing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Cancer Genome Sequencing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Cancer Genome Sequencing Market Share Forecast by Type (2025-2030)
Figure 65. Global Cancer Genome Sequencing Sales Forecast by Application (2025-2030)
Figure 66. Global Cancer Genome Sequencing Market Share Forecast by Application (2025-2030)
